explore -WSS

explore

author：Wikipedia 2025-09-28 23:48:08 - browse：1689

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Tome Biosciences co

hotspot

WSS

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

STAT Boddities: What happens to the brain when we get scared?

HCA discloses massive data breach affecting 11 million patients

Oak trusses raised to roof of fire

Study: Pain burden is higher in Black NFL players than white ones

focus

explore

focus

Drug repurposing or repositioning? The language matters

NIH fellows want a pay raise. Will that mean less money for grants?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lecanemab for Alzheimer's is coming. Is the health system ready?

Moonlake's readout produced a cash windfall. Risks remain

Congress must protect the remaining independent doctors

Drug repurposing or repositioning? The language matters

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Trump demands the U.S. pay no more for drugs than other countries … again

Retired US general questions alleged Putin, Prigozhin meeting

focus

Retired US general questions alleged Putin, Prigozhin meeting

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout Newsletter: Amylyx, Aurinia, and IQVIA

HCA discloses massive data breach affecting 11 million patients

Study gives hint on South Asians’ higher risk of cardiovascular disease

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

hotspot

entertainment

hotspot

hotspot